Literature DB >> 23107693

Production of dipeptidyl peptidase IV inhibitory peptides from defatted rice bran.

Tadashi Hatanaka1, Yosikazu Inoue, Jiro Arima, Yuya Kumagai, Hirokazu Usuki, Kayoko Kawakami, Masayo Kimura, Takafumi Mukaihara.   

Abstract

The insulinotropic hormone glucagon-like peptide-1 is metabolised extremely rapidly by the ubiquitous enzyme dipeptidyl peptidase IV (DPP-IV). Therefore, human DPP-IV is a key regulator involved in the prevention and treatment of type 2 diabetes. To simplify the method of producing an inhibitory peptide against DPP-IV, we focused on rice bran (RB) as a source and subjected proteins from defatted RB to enzymatic proteolysis using 2 commercial enzymes. The RB peptides produced with Umamizyme G exhibited 10 times the inhibitory activity as those produced with Bioprase SP. The half-maximal inhibitory concentration (IC(50)) value of the RB peptides was 2.3 ± 0.1mg/ml. Leu-Pro and Ile-Pro were identified as the inhibitory peptides among the RB peptides produced with Umamizyme G. Ile-Pro was the strongest DPP-IV inhibitor among the 15 Xaa-Pro dipeptides and Pro-Ile tested. Ile-Pro competitively inhibited DPP-IV (K(i)=0.11 mM). Mass spectrometry indicated that the contents of Leu-Pro and Ile-Pro in the RB peptides were 2.91 ± 0.52 μg/mg.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23107693     DOI: 10.1016/j.foodchem.2012.02.183

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  23 in total

Review 1.  Food protein-derived bioactive peptides in management of type 2 diabetes.

Authors:  Prasad Patil; Surajit Mandal; Sudhir Kumar Tomar; Santosh Anand
Journal:  Eur J Nutr       Date:  2015-07-08       Impact factor: 5.614

2.  Dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucagon-like peptide (GLP-1) secretion in arsenically safe pigmented red rice (Oryza sativa L.) and its product.

Authors:  Duyi Samyor; Danielle Calderwood; Manus Carey; Amit B Das; Brian D Green; Sankar C Deka
Journal:  J Food Sci Technol       Date:  2022-04-11       Impact factor: 3.117

Review 3.  Health Benefits of Cereal Grain- and Pulse-Derived Proteins.

Authors:  Jenny Bouchard; Maneka Malalgoda; Joanne Storsley; Lovemore Malunga; Thomas Netticadan; Sijo Joseph Thandapilly
Journal:  Molecules       Date:  2022-06-10       Impact factor: 4.927

4.  AntiDMPpred: a web service for identifying anti-diabetic peptides.

Authors:  Xue Chen; Jian Huang; Bifang He
Journal:  PeerJ       Date:  2022-06-14       Impact factor: 3.061

5.  Peptide array on cellulose support--a screening tool to identify peptides with dipeptidyl-peptidase IV inhibitory activity within the sequence of α-lactalbumin.

Authors:  Isabelle M E Lacroix; Eunice C Y Li-Chan
Journal:  Int J Mol Sci       Date:  2014-11-13       Impact factor: 5.923

6.  Predicted Release and Analysis of Novel ACE-I, Renin, and DPP-IV Inhibitory Peptides from Common Oat (Avena sativa) Protein Hydrolysates Using in Silico Analysis.

Authors:  Stephen Bleakley; Maria Hayes; Nora O' Shea; Eimear Gallagher; Tomas Lafarga
Journal:  Foods       Date:  2017-12-04

Review 7.  Marine Peptides as Potential Agents for the Management of Type 2 Diabetes Mellitus-A Prospect.

Authors:  En-Qin Xia; Shan-Shan Zhu; Min-Jing He; Fei Luo; Cheng-Zhan Fu; Tang-Bin Zou
Journal:  Mar Drugs       Date:  2017-03-23       Impact factor: 5.118

8.  The development of bioactive peptides from dietary proteins as a dipeptidyl peptidase IV inhibitor for the management of type 2 diabetes.

Authors:  Chia-Ling Jao; Chuan-Chuan Hung; Yu-Shan Tung; Pei-Yi Lin; Meng-Chun Chen; Kuo-Chiang Hsu
Journal:  Biomedicine (Taipei)       Date:  2015-08-13

9.  Effects of yam dioscorin interventions on improvements of the metabolic syndrome in high-fat diet-induced obese rats.

Authors:  Shen-Liang Shih; Yin-Shiou Lin; Shyr-Yi Lin; Wen-Chi Hou
Journal:  Bot Stud       Date:  2015-02-25       Impact factor: 2.787

Review 10.  Roles of Dietary Bioactive Peptides in Redox Balance and Metabolic Disorders.

Authors:  Qinqin Qiao; Liang Chen; Xiang Li; Xiangyang Lu; Qingbiao Xu
Journal:  Oxid Med Cell Longev       Date:  2021-06-09       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.